In this review:
Bevacizumab treatment of refractory neuroblastoma in children
A new CXCR4 agonist for stem cell collection
Education and support for haematology-oncology nurses
Study endpoints used in FDA approvals
Treatment outcomes for pregnant Hodgkin lymphoma patients
Brentuximab vedotin for Hodgkin lymphoma
Impact of FL3-ITD mutations on AML prognosis
Triglyceride as a prognostic biomarker in APL
Treatment outcomes in elderly DLBCL patients
IL-6 as a prognostic biomarker in AML
Coagulation factors and clinical response in NKTCL
Please login below to download this issue (PDF)